PubMed COVID-19 Clinical Care

CONCLUSION: Every fourth out of ten suffered from personal burnout, one-third from work-related burnout, and one-seventh from client-related burnout among healthcare providers during the COVID-19 pandemic. Healthcare systems must take care of

No abstract

CONCLUSION: Children with IEIs infected with SARS-CoV-2 may experience higher rates of ICU admission and mortality in comparison with the immunocompetent pediatric populations. Underlying immune defects does seem to be independent risk factors for

BACKGROUND: The purpose of this paper was to systematically evaluate the application value of artificial intelligence in predicting mortality among COVID-19 patients.

CONCLUSION: Further research should be conducted, mainly concerning vaccines and vaccination of the aged, owing to the need for and importance of immunization in this risk group, including assessing the long-term effects of vaccines.

The early phase of the COVID-19 pandemic prompted a repurposing of antiviral and immunomodulatory drugs as investigational therapeutics, including hydroxychloroquine and chloroquine. While antimalarials have been well-refuted as a treatment for COVID

The outbreak of the COVID-19 in early 2020 and the recurring epidemic in later years have disturbed China's economy. Moreover, China's demographic dividend has been disappearing due to its fastest aging population and declining birth rate. The birth

The first case of coronavirus disease 2019 in Colombia was detected on March 6, 2020. Subsequently, schools, colleges, and universities were closed on March 26, which forced a massive migration to virtual education and impacted laboratory-based

The Coronavirus disease 2019 (COVID-19) global outbreak and its continued growth and mutation into various forms emphasize the need for effective disinfectants to assist in the reduction of the virus's spread from individual to individuals and

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is a threat to the global healthcare system and economic security. As of July 2020, no specific drugs or vaccines are yet